Kelly A Curtis
Overview
Explore the profile of Kelly A Curtis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
397
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Curtis K, Rudolph D, Pan Y, Delaney K, Anastos K, DeHovitz J, et al.
PLoS One
. 2021 Jul;
16(7):e0242641.
PMID: 34197451
Background: Given the challenges and costs associated with implementing HIV-1 incidence assay testing, there is great interest in evaluating the use of commercial HIV diagnostic tests for determining recent HIV...
2.
Parker I, Khalil G, Martin A, Martin M, Vanichseni S, Leelawiwat W, et al.
AIDS Res Hum Retroviruses
. 2020 Oct;
37(3):189-195.
PMID: 33126825
Preexposure prophylaxis (PrEP) is an effective HIV prevention tool, although effectiveness is dependent upon adherence. It is important to characterize the impact of PrEP on HIV antibody responses in people...
3.
Curtis K, Campbell E, Hanson D, Rudolph D, Duwve J, Blosser S, et al.
J Acquir Immune Defic Syndr
. 2019 Jan;
80(4):454-460.
PMID: 30624297
Background: Laboratory assays for determining recent HIV-1 infection are an important public health tool for aiding in the estimation of HIV incidence. Some incidence assay analytes are remarkably predictive of...
4.
Granade T, Kodani M, Wells S, Youngpairoj A, Masciotra S, Curtis K, et al.
J Virol Methods
. 2018 Jun;
259:60-65.
PMID: 29874550
Real-time PCR assays for nucleic acid testing (NAT) of hepatitis viruses A-E and for HIV-1 and HIV-2 have been developed; however, a multiplex assay that can simultaneously detect all of...
5.
Curtis K, Morrison D, Rudolph D, Shankar A, Bloomfield L, Switzer W, et al.
J Virol Methods
. 2018 Feb;
255:91-97.
PMID: 29474813
Isothermal nucleic acid amplification techniques, such as reverse-transcription loop-mediated isothermal amplification (RT-LAMP), exhibit characteristics that are suitable for the development of a rapid, low-cost NAT that can be used at...
6.
Parker I, Price K, Singletary T, Srinivasan P, Smith J, Curtis K
J Immunol Methods
. 2017 Jul;
450:34-40.
PMID: 28750871
Evaluating antibody maturation provides valuable data to characterize immune responses to HIV infection and can provide insight into biomedical intervention efficacy. It is important to develop assays that evaluate antibody...
7.
Curtis K, Hanson D, Price K, Owen S
PLoS One
. 2017 May;
12(5):e0176593.
PMID: 28472089
The availability of reliable laboratory methods for determining recent HIV infection is vital for accurate estimation of population-based incidence. The mean duration of recent infection (MDRI) and false recent rate...
8.
Curtis K, Rudolph D, Morrison D, Guelig D, Diesburg S, McAdams D, et al.
J Virol Methods
. 2016 Sep;
237:132-137.
PMID: 27616198
Early and accurate diagnosis of HIV is key for the reduction of transmission and initiation of patient care. The availability of a rapid nucleic acid test (NAT) for use at...
9.
Curtis K, Price K, Niedzwiedz P, Masciotra S, Owen M
AIDS Res Hum Retroviruses
. 2016 Feb;
32(6):561-3.
PMID: 26887862
The effects of antiretroviral therapy (ART) on the performance of HIV incidence assays have been well documented. To improve upon current assay approaches or focus the development of future assays,...
10.
Rudolph D, Sullivan V, Owen S, Curtis K
PLoS One
. 2015 May;
10(5):e0126609.
PMID: 25993381
A rapid, cost-effective diagnostic test for the detection of acute HIV-1 infection is highly desired. Isothermal amplification techniques, such as reverse-transcription loop-mediated isothermal amplification (RT-LAMP), exhibit characteristics that are ideal...